The world's second-largest economy, with thousands of companies listed in Shanghai and Shenzhen. Strong in banking, manufacturing, consumer brands and fast-growing tech, though heavily shaped by government policy.
Index·
No index history for this market yet.
Why is China moving?
Latest
▲1▼1
AI chip demand wobbles, tariff cuts and biotech deals lift China
▼
AI chip demand fears hit Chinese tech OpenAI paused its most advanced AI training over safety, and Beijing may let Alibaba and ByteDance buy Nvidia's RTX Pro 5500 chips. Chinese chipmakers fell hard: Cambricon -5.7%, SMIC -3.7%, Moore Threads -6.3%. This threatens demand and market share for China's domestic AI chip champions.
A major new force pushing China's tech sector down, with named companies and clear market impact.
▲
US-China tariff cuts on $60B of goods The US and China agreed to cut tariffs on 1,696 product codes worth $30 billion each side, covering appliances, toys, food and medical equipment, and extended their trade truce to January 2027. Chinese appliance makers Joyoung and Bear Electric jumped on the news, easing trade-war pressure.
A concrete new trade de-escalation that directly lifts Chinese exporters and market sentiment.
◆
Computing power orders surge, but financing and chip sourcing are risky Fengzhushou signed 9.68 billion yuan of computing power contracts, and Aoni Electronics signed GPU card deals worth 1.82 billion yuan plus $232 million. But a report says state-backed financing bought restricted Nvidia B300 chips, raising export-control and compliance risks for the AI infrastructure buildout.
Shows both the scale of China's AI infrastructure demand and the regulatory risks around it.
Q3 2026
▲2▼1
AI tech boom lifts China stocks, but growth and trade risks weigh
▲
AI-driven tech boom China's tech sector surged as chip, memory, optical, and server companies reported profit jumps. Huawei's AI computing advances and ChangXin's IPO boosted confidence, while Nvidia H200 shipments eased supply constraints.
This was the main positive force lifting China markets in Q3.
▲
Broad market support Biotech, lithium, and EV exports gained, supported by share buybacks and state support. These factors lifted sentiment beyond the tech sector, helping to broaden the market rally.
It shows the positive drivers were not limited to tech, giving a fuller picture.
▼
Economic and trade headwinds Weak 4.3% GDP growth, record household loan defaults, foreign downgrades, and new US tariffs and export bans on transceivers, robots, drones, solar equipment, and CXMT memory pressured exporters. Solar overcapacity caused heavy losses.
These were the major negative forces weighing on China markets during the quarter.
◆
Late-quarter uncertainties OpenAI and Anthropic warned of an AI slowdown, Beijing's possible Nvidia purchases threatened domestic chipmakers, and BYD's sales fell amid price wars. Vanke needed regulatory shielding, while GAC-FAW consolidation carried execution risk.
These late developments added uncertainty and tempered the earlier optimism.
News movingChina
United KingdomChinaUnited States
China▲
UK New Car Sales Rise 12% in September, Driven by EVs and Chinese Brands
The UK new car market recorded its best September since 2017, with registrations up 12% year-on-year to 350,518 units, according to figures released on the 2nd by the Society of Motor Manufacturers and Traders. Supported by strong demand for electric vehicles, battery electric vehicle registrations in September rose 36% year-on-year to 99,199 units, taking a market share of 28.3%. In contrast, petrol car registrations fell 6.7% and hybrid vehicle registrations fell 4.2%. Diesel car registrations rose 11.5% in September, but were down 7% over the January-September period compared with a year earlier, with their market share shrinking to about 4.5% this year. By brand, the Jaecoo 7 SUV from China's Chery was the best-selling model, while among battery electric vehicles the Sealion 7 SUV from China's BYD ranked third, behind US EV giant Tesla's Model 3 sedan and Model Y SUV. On a year-to-date basis, battery electric vehicles account for only 26.2% of total sales, well below the 33% mandated for 2026 and also short of last year's 28% target.
First Chinese auto show held in Argentina as Chinese brands' sales share surges from 2% to 10%
Argentina's first Chinese auto show opened on the 2nd in the capital, Buenos Aires. Under President Milei, the country's auto market is shifting from strong protectionism toward a more open and competitive environment. Helped by a measure allowing up to 50,000 electric and hybrid vehicles to be imported duty-free in 2026, Chinese brands have been entering the market one after another, and in August the Chinese brands' share of passenger car and light commercial vehicle sales reached 10%, up from about 2% in late 2025. Chinese electric vehicle giant BYD has become the ninth-largest auto brand by sales since entering Argentina in late 2025. More than 20 Chinese brands exhibited at the auto show, including Geely, Chery, Great Wall Motor and Dongfeng Motor, and Sebastian Beato, president of the Argentine auto dealers association, said the remarkable growth of Chinese brands is prompting the domestic auto industry to produce new models.
Electrification & Mobility › China NEV Leaders ▲Competition
002594.CS · Demand · Positive BYD became Argentina's ninth-largest auto brand by sales since entering in late 2025, with Chinese brands' share reaching 10%.
0175.HK · Demand · Positive Geely exhibited at Argentina's first Chinese auto show as Chinese brands' sales share surged to 10% on duty-free EV import measure.
601633.CG · Demand · Positive Great Wall Motor exhibited at Argentina's first Chinese auto show as Chinese brands' sales share surged to 10%.
9973.HK · Demand · Positive Chery exhibited at Argentina's first Chinese auto show amid Chinese brands' sales share rising from 2% to 10%.
Daqo New Energy Fair Value Cut 18% as JPMorgan and Goldman Split on Rating
Daqo New Energy's fair value estimate has been trimmed from about US$23.95 to about US$19.65, an adjustment of roughly 18%, as analysts remain sharply divided on the stock. JPMorgan maintains an Overweight rating with a revised US$22 price target, still above the updated fair value estimate, while Goldman Sachs shifted to a Sell rating with a reduced US$10 target, citing a Q2 non GAAP net loss driven by lower recognized average selling prices and higher SG&A expenses. The company issued new production guidance for the third quarter of 2026 targeting polysilicon output of about 40,000 MT to 45,000 MT, and for the full year 2026 guided to polysilicon production of about 160,000 MT to 180,000 MT, including the impact of annual facility maintenance. Daqo New Energy was also removed from the FTSE All World Index in US$ terms, and Reuters reported that the U.S. government is preparing a price floor and tariffs on polysilicon to support domestic factories, with Daqo New Energy cited among the companies expected to be affected. In the updated model, revenue growth was trimmed from about 32.87% to about 30.82%, net profit margin moved from about 1.77% to about 6.50%, the future P/E was cut from about 97.65x to about 23.46x, and the discount rate edged higher from about 12.27% to about 12.37%.
DQ · Capital · Neutral Fair value cut ~18% with JPMorgan Overweight ($22 target) vs Goldman Sell ($10 target) after Q2 non-GAAP net loss on lower ASPs and higher SG&A.
DQ · Tariff · Negative US government preparing a polysilicon price floor and tariffs, with Daqo cited among companies expected to be affected.
688303.CG · Capital · Neutral Parent Daqo New Energy's fair value cut and split analyst ratings (JPMorgan Overweight vs Goldman Sell) after a Q2 net loss.
688303.CG · Tariff · Negative US polysilicon price floor and tariffs cited as affecting Daqo New Energy, the parent of Xinjiang Daqo.
Tesla Q3 Deliveries Beat Estimates by 5.3% as Energy Storage Misses
Tesla's third-quarter deliveries beat company-compiled analyst expectations by 5.3%, though they declined 2.1% from a year earlier, a drop partly cushioned by Q3 2025's tax credit boost. Seeking Alpha analyst Oliver Rodzianko said the biggest takeaway is that traditional EV demand remains resilient as Tesla pivots toward autonomous taxi services and humanoid robotics as its dominant operating models, while energy storage deployment numbers missed expectations. Rodzianko noted that Chinese rival BYD saw its battery-electric passenger-car sales rise 30.9% year-over-year in the third quarter, underscoring fierce competition in China. Analyst Alexander Grover argued the delivery number is a distraction, since Tesla's valuation assumes unsupervised self-driving at scale, and flagged that Alphabet's Waymo is running more than 500,000 paid driverless rides a week across 15 U.S. metros with LiDAR in its stack, while Tesla still does not disclose how many of its robotaxis run without a safety monitor.
Sanofi, Novartis and Novo Nordisk Lead Week of Multi-Billion-Dollar Healthcare Deals
A Delaware federal judge on Monday rejected requests from Pfizer, BioNTech and Moderna to dismiss lawsuits filed by Bayer's Monsanto unit over their use of US Patent No. 7,741,118, a patent related to mRNA technology, with Judge William Bryson saying the companies failed to prove the patent was invalid or not infringed by their COVID-19 vaccines. Sanofi agreed to a deal worth up to $8B, including $1B upfront, with Regeneron to jointly develop four long-acting immunology therapies, led by the clinical-stage IL-13 monoclonal antibody REGN20423. China's Abogen Biosciences signed a licensing and option agreement with Novartis worth up to $7.8B, comprising a $575 million upfront payment and up to approximately $7.2 billion in potential milestone payments if all options on all programs are exercised, covering an exclusive worldwide license to Abogen's lead asset ABO2203. Jiangsu Hengrui Pharmaceuticals agreed to license global rights to its experimental obesity drug HRS-1596 to Novo Nordisk in a deal worth up to $2.6B, with $300M upfront and the transaction expected to close in Q4 2026. Meanwhile, the S&P 500 Health Care Sector Index slipped 2.66% for the week, with Incyte down 6.93% and Regeneron down 6.71% among the top decliners, while McKesson rose 4.11% and Cardinal Health gained 3.67%.
Hong Kong Q3 share sales hit record $47.5 billion on AI deal boom
Hong Kong share sales raised a record $47.5 billion in the third quarter as Chinese technology companies tapped investors for capital to fund artificial intelligence expansion, Bloomberg reported. Initial public offerings, placements and block trades during the July-to-September period produced the largest fundraising haul ever for those months, pushing the city's total for 2026 above $92 billion and putting Hong Kong within reach of the $112.5 billion annual record set in 2021. Alibaba Group's $10.2 billion follow-on offering was the quarter's largest transaction, while Zhongji Innolight raised almost $8 billion in Hong Kong's biggest listing in nearly seven years. AI model developer Z.AI has raised $9.6 billion this year through its IPO, placements and convertible bonds, and MiniMax, Shanghai Iluvatar CoreX Semiconductor and Shanghai Biren Technology also returned to investors shortly after their IPO lockups expired. The boom spread across Asia-Pacific, where third-quarter share sales exceeded $120 billion, the highest for the period in six years, with India raising a record $26 billion since July on domestic liquidity. Investor appetite is becoming more selective as markets weaken: the MSCI Asia-Pacific Index fell as much as 7% in July amid questions about returns from heavy AI spending, and only two of Hong Kong's 10 largest deals since July are currently trading above their offer prices.
Chinese Online's 2.833 billion yuan private placement plan questioned by Shenzhen Stock Exchange; fundraising scale exceeds net assets by 10 times
Chinese Online announced on the evening of September 30 its largest refinancing plan since listing, planning to issue A-shares to no more than 35 specific investors, with total proceeds not exceeding 2.833 billion yuan, of which 864 million yuan will be used for original literature copyright procurement, the largest single use of the funds. Just two days after the plan was disclosed, the Shenzhen Stock Exchange issued an inquiry letter on October 2, raising questions on five aspects: the use of proceeds, the investment projects, the impact on the company's key financial indicators, the termination of the previous refinancing, and the relationship with its Hong Kong IPO. The company is required to reply in writing and disclose the response before October 8. The inquiry letter pointed out that as of the end of June 2026, Chinese Online had net assets of 263 million yuan, cash and cash equivalents of 277 million yuan, and interest-bearing debt of 428 million yuan. From January to June 2026, net operating cash flow was 127 million yuan, and net profit before and after deducting non-recurring items was negative 43 million yuan and negative 48 million yuan respectively. The Shenzhen Stock Exchange required the company to explain the reasonableness of the financing amount in light of the fact that the fundraising scale is more than 10 times its net assets and the above financial data. The company has not yet disclosed its response to the inquiry letter. In the secondary market, Chinese Online's share price hit an intraday high of 43.80 yuan per share on February 11, 2026, a new high in nearly 10 years, and closed at 23.37 yuan per share on September 30, down 46.63% from the year's high.
300364.CS · Capital · Negative Shenzhen Stock Exchange questions Chinese Online's 2.833 billion yuan private placement, which is over 10 times its net assets, raising financing and valuation concerns.
Fourth round of tire industry price hikes this year takes effect, with all-category products raised by 2% to 5%
Entering October, the fourth round of concentrated price hikes in China's tire industry this year has officially entered its implementation period. Leading tire companies including General Science Technology, Zhongce Rubber, Sailun Tire, and Linglong Tire have raised prices by 2% to 5% across all product categories such as all-steel tires, semi-steel tires, and off-the-road tires. This is already the fourth round of concentrated price-increase notices issued by the tire industry since March this year. In its price adjustment notice, General Science Technology pointed to raw materials as the reason for the increase, saying that prices of natural rubber, synthetic rubber, and carbon black have continued to rise sharply, causing tire manufacturing costs to climb rapidly. Raw materials account for more than 70% of tire production costs, with natural rubber, synthetic rubber, and carbon black together accounting for more than 60%. The simultaneous rise of these three major raw materials is the fundamental driver of this round of price increases. On carbon black, data from SunSirs shows that on October 1, the benchmark price of carbon black was reported at 11,692.86 yuan per ton, up about 59.74% year on year. On natural rubber, as of the end of the third quarter, the main Shanghai rubber futures contract closed above the 20,000 yuan per ton mark, while the average spot price in the domestic market over the same period was about 19,400 yuan per ton, up 31% year on year. On synthetic rubber, according to SunSirs data from October 1, the benchmark price of butadiene rubber was reported at 16,220 yuan per ton, up 39% year on year, and the benchmark price of styrene-butadiene rubber was reported at 16,175 yuan per ton, up about 36% year on year. According to data from Longzhong Information, as of September 29, the raw material cost index for semi-steel tires and the raw material cost index for all-steel tires both rose about 25% year on year. Zhongtai Securities believes that after cost disturbances ease, leading tire companies are expected to return to high year-on-year growth, but industry divergence will further intensify.
601500.CG · Pricing · Positive General Science Technology is a named leader raising prices 2%-5% across all categories, citing raw-material cost inflation
601058.CG · Pricing · Positive Sailun Tire is named among leading tire makers implementing a 2%-5% all-category price hike, lifting its product prices
601966.CG · Pricing · Positive Linglong Tire is named among leading tire companies implementing the 2%-5% all-category price increase
603049.CG · Pricing · Positive Zhongce Rubber is named among leading tire makers raising prices 2%-5% across all product categories
CanSino issues urgent announcement after hitting daily limit up: mRNA cancer vaccine development still in early stage
CanSino surged to the daily limit up on the last trading day before the National Day holiday, with its share price breaking through the previous consolidation range and reaching a new stage high since April 2023, while its H shares also moved higher in tandem. On October 1, CanSino issued a stock movement announcement stating that the company had noted recent market developments regarding mRNA technology, as well as the release or planned disclosure of overseas clinical stage data for mRNA cancer vaccines. CanSino made clear that the mRNA platform is one of the technology platforms in its portfolio, and that the company is developing preventive mRNA vaccines and therapeutic biologics, as well as related delivery systems. In the therapeutic area, it is advancing research and development of mRNA vaccines for indications including glioblastoma, rhabdomyosarcoma, and cervical cancer, as well as the development of In Vivo CAR-related therapies, all of which are currently in early stages. In August this year, Merck and Moderna jointly announced that their personalized messenger RNA cancer vaccine met its primary endpoint in a Phase III trial, making it the first therapeutic vaccine proven effective in a large-scale Phase III clinical trial globally. On August 25, CanSino's official WeChat account announced that its subsidiary CanSino Shanghai Biologics had formally signed a strategic cooperation framework agreement with Depush Hangzhou Biotechnology for the joint development of personalized therapeutic mRNA cancer vaccines. The two parties will jointly advance the research, development, and commercialization of personalized therapeutic mRNA cancer vaccines, with a global focus on gastrointestinal solid tumors and rare tumor treatment areas. It should be noted that CanSino's entire mRNA product line has not yet moved beyond the early research and development stage, and innovative drug development carries multiple uncertainties including technical failure, clinical results falling short of expectations, and approval delays, while competition in the domestic mRNA vaccine sector is also becoming increasingly intense.
688185.CG · Technology · Neutral CanSino clarified its mRNA cancer vaccine programs (glioblastoma, rhabdomyosarcoma, cervical cancer, In Vivo CAR) remain in early stages despite the stock's limit-up.
德普世（杭州）生物科技有限责任公司 · Demand · Positive Depush Hangzhou signed a strategic cooperation framework agreement with CanSino Shanghai Biologics to jointly develop personalized therapeutic mRNA cancer vaccines.
MRK · Technology · Positive Merck's partnered personalized mRNA cancer vaccine met its primary endpoint in a Phase III trial, the first such therapeutic vaccine success.
MRNA · Technology · Positive Moderna's jointly announced personalized mRNA cancer vaccine met its primary endpoint in a Phase III trial.
BTIG: Half-Size Robots Dominate Humanoid Shipments, Only 32% Full-Size
BTIG analyst Jesse Sobelson said the humanoid robot industry has split into two largely separate product classes, with half-size systems, mostly Chinese, measuring roughly 94–138 cm and weighing 12–40 kg, and full-size machines generally standing 165–190 cm tall and weighing 47–90 kg. BTIG estimates that major players Unitree and AgiBot had built approximately 31K humanoids through June, of which only about 9.8K, or 32%, were full-size units of any type, and full-size bipeds represented only about 13% of cumulative production. Sobelson warned that industry shipment figures can be misleading if interpreted as evidence of broad adoption of human-scale robotic labor, since many of the estimated +40K cumulative shipments through mid-2026 were smaller, lower-cost Chinese units rather than industrial-grade humanoid bipeds. Hangzhou-based Unitree's smaller R1 and G1 products are priced approximately from $4,900 to $21,500 depending on configuration, and BTIG expects Unitree's 2026 shipments to at least double from around 6,000 in 2025, while the company plans for an annual capacity of 30K units. Tesla is the major potential challenger to the current half-size dominance, with BTIG saying Tesla anticipated Optimus production at Fremont later in 2026 but warned that initial output would be slow because the new line includes about 10K unique parts; Sobelson views Tesla, along with Figure, 1X, and Boston Dynamics, as the key players if there is to be a future shift toward full-size systems.
688836.CG · Demand · Positive BTIG estimates Unitree built ~31K humanoids with 2026 shipments to at least double from ~6,000 in 2025, and plans 30K annual capacity.
智元机器人 · Demand · Positive BTIG estimates AgiBot (智元机器人) is a major player in the half-size humanoid build, contributing to the ~31K cumulative units through June.
TSLA · Technology · Neutral BTIG says Tesla is the key potential challenger to half-size dominance, with Optimus production anticipated at Fremont later in 2026 but slow initial output due to ~10K unique parts.
1X Technologies · Technology · Neutral 1X Technologies is mentioned only as a key player for a potential future shift to full-size systems, with no concrete development.
Boston Dynamics · Technology · Neutral Boston Dynamics is named only as one of the key players if the industry shifts toward full-size systems, with no specific development.
Betaini's first self-developed medical aesthetic injectable BTN001 approved, first interim dividend launched simultaneously
Betaini's self-developed injectable sodium hyaluronate solution BTN001 has officially received approval from the National Medical Products Administration, obtaining a Class III medical device registration certificate with registration number 20263131919. This is the group's first self-developed Class III medical device approved for market. Institutional research reports note that Betaini, leveraging its Winona sensitive-skin base and Acoman clinical channel, uses BTN001 to close the loop of pre-operative stabilization, intra-operative injection, and post-operative repair, strengthening its full-cycle medical aesthetic service capability. The new product is restricted to medical institutions, with high barriers and large pricing space, and is expected to open a second growth curve. In terms of shareholder returns, as of August 31, 2026, the company had cumulatively repurchased 3.6997 million shares, accounting for 0.8734% of total share capital, with a total transaction amount of approximately 120 million yuan. At the same time, it launched its first interim dividend, proposing a cash dividend of 1.50 yuan per 10 shares to all shareholders, with an estimated total payout of approximately 62.639 million yuan. Controlling shareholder Guo Zhenyu also pledged in April this year not to reduce his holdings within 12 months. In the first half of 2026, Betaini achieved operating revenue of 2.592 billion yuan, up 9.27% year-on-year, net profit attributable to the parent of 292 million yuan, up 18.30% year-on-year, and non-GAAP net profit attributable to the parent of 246 million yuan, a sharp increase of 34.85% year-on-year. Net cash flow from operating activities was 394 million yuan, up 13.53% year-on-year. Gross margin reached 74.62%, and the selling expense ratio fell 3.64 percentage points year-on-year to 50.53%. However, Betaini's share price has fallen about 15% cumulatively this year, hovering around 30 to 35 yuan from late June to late September. As of September 30, it closed at 32.70 yuan per share, with a latest total market value of approximately 13.8 billion yuan.
300957.CS · Capital · Positive Company launched its first interim dividend of 1.50 yuan per 10 shares and had cumulatively repurchased 3.6997 million shares for ~120 million yuan.
300957.CS · Technology · Positive Betaini's first self-developed Class III medical device BTN001 (sodium hyaluronate injectable) received NMPA approval, opening a second growth curve.
Guangda Special Materials Earnings Call Addresses Employee Stock Ownership and AI Applications
Guangda Special Materials held its 2026 semi-annual earnings briefing online on September 30, responding to questions about artificial intelligence applications, the employee stock ownership plan, product expansion, and raw material price fluctuations. The company's 2026 semi-annual report shows operating revenue of 2.323 billion yuan, down 8.36 percent year on year; net profit attributable to the parent company of 12.34 million yuan, down 93.33 percent; non-GAAP net profit attributable to the parent company of 11.32 million yuan, down 93.67 percent; net operating cash flow of negative 231 million yuan; and a main business gross margin of 13.37 percent, down 7.31 percentage points from the same period last year, mainly affected by reduced new installed capacity in the downstream wind power industry. Regarding the progress of the employee stock ownership plan that investors are concerned about, the company responded that within six months after approval by the shareholders' meeting, the management committee of the employee stock ownership plan will complete the purchase of underlying shares through methods such as buying the company's A-shares on the secondary market, and the company will complete the position building gradually during the building period based on market conditions. On artificial intelligence, the company said the relevant applications are still in the evaluation and testing stage, have not formed large-scale applications, and have no material impact on company performance. In terms of product expansion, the company has passed the international aerospace quality management system certification AS9100D, and its production technology for high-purity superalloy electroslag ingots has been applied in fields such as aircraft engines and gas turbines. Homogeneous fine-grained superalloy forgings have been supplied in batches to aircraft engines, rocket engines, and gas turbines. The aerospace superalloy UNS N07041 has achieved batch supply, and the company has carried out cooperation with relevant customers in the aerospace field and achieved batch supply.
Huichuangda Plans Cash Acquisition of 100% Equity in Chuncao Technology
A-share consumer electronics concept stock Huichuangda announced that it plans to acquire 100% equity in Dongguan Chuncao Grinding Technology Co., Ltd., known as Chuncao Technology, through a combination of direct and indirect acquisitions in cash. Upon completion of the transaction, Chuncao Technology will become a wholly-owned subsidiary of Huichuangda and be included in its consolidated financial statements. Huichuangda's main business is the research, development, design, production and sales of light guide structural components and assemblies, and precision key switch structural components and assemblies, with products applied in consumer electronics, automotive electronics, new energy and other fields. Chuncao Technology is a systematic service provider specializing in grinding and polishing intelligent surface treatment equipment, automated production lines and polishing consumables. It has become a qualified supplier to many leading companies in 3C, automotive parts and other fields, with well-known customers including Foxconn, Lens Technology, Luxshare Precision, Biel Crystal, BYD, Jingyan Technology and Gengde Electronics. In the secondary market, Huichuangda's share price has recently fluctuated upward. As of the close on September 30, Huichuangda fell 8.22% on the day to close at 60.97 yuan per share, with a total market value of 10.5 billion yuan.
300909.CS · Capital · Positive Huichuangda plans a cash acquisition of 100% equity in Chuncao Technology, which will become a wholly-owned consolidated subsidiary.
东莞市春草研磨科技有限公司 · Capital · Positive Chuncao Technology is being fully acquired by Huichuangda in cash, becoming its wholly-owned subsidiary.
BYD's September Global Sales Rise 17% on Export Surge, Fifth Straight Month of Gains
China's electric vehicle giant BYD sold 463,561 vehicles worldwide in September, up 17% from a year earlier and marking a fifth consecutive month of growth, supported by strong exports. Overseas shipments of passenger cars and pickup trucks surged 153.9% to 179,877 units, growing in prominence as a pillar offsetting sluggish domestic demand. The growth rate slowed from 17.8% in August. Sales for January through September totaled 3,131,576 units, of which overseas shipments of passenger cars and pickup trucks accounted for 1,337,831 units. Competition is intensifying in China's domestic market, with rival Geely unveiling a faster charging system, and according to securities firms, BYD expects its overseas shipments to exceed 2.5 million units in 2027.
ST Dou Shen signs computing power contract worth about 800 million yuan for 60 months
On the evening of September 30, ST Dou Shen (300010) disclosed that its wholly owned subsidiary Dou Shen Hong Kong recently signed a Cloud Computing Service Agreement with a certain customer, with a total contract value of about 119 million US dollars, equivalent to about 800 million yuan. The service period of the agreement is 60 months, and the customer will prepay 40 percent of the total order amount as agreed and pay service fees monthly. ST Dou Shen did not disclose specific customer information, stating that the contract involves confidentiality clauses and that it has completed internal procedures for exemption from disclosure of confidential information. The company said the contract is a large-scale computing power service project for the implementation of its intelligent computing service business, an important practice in cultivating a second growth curve, and reflects the extension of its business from AI applications to the computing power infrastructure field. Wind data shows that since mid-August 2026, ST Dou Shen's stock price has risen by more than 120 percent cumulatively.
豆神香港 · Demand · Positive Dou Shen Hong Kong itself signed the ~800M yuan 60-month cloud computing service agreement with a customer, with 40% prepayment.
300010.CS · Demand · Positive Wholly owned subsidiary Dou Shen Hong Kong signed a ~$119M/800M yuan 60-month cloud computing service contract with a customer, a large-scale computing power service order.
ST Qingyue core technical staff member Sun Jian resigns, second departure in three months
On the evening of September 30, ST Qingyue announced that core technical staff member Sun Jian had recently submitted his resignation for personal reasons and will no longer hold any position at the company. Sun Jian served as a director and employee representative director from 2018 to September 2026, and as general manager of Kunshan Mengxian Electronic Technology from 2019 to September 2026. As of the announcement date, he indirectly held 1,197,800 shares in the company through three partnership enterprises. Before this change, ST Qingyue had four core technical staff members: Gao Yudi, Sun Jian, Liu Hongjun, and Ma Zhongsheng. After the change, three will remain: Gao Yudi, Liu Hongjun, and Ma Zhongsheng. Earlier, on June 18, 2026, core technical staff member Zhang Feng had already resigned for personal reasons, meaning the company has lost two core technical staff members in just over three months. In addition, on September 10, 2026, the company received a prior notice of delisting from the Second Management Department of Listed Companies at the Shanghai Stock Exchange. By that date, the company's stock had closed below 1 yuan per share for 20 consecutive trading days. In the first half of 2026, the company achieved operating revenue of 276 million yuan, down 16.26 percent year on year, with a net loss attributable to the parent company of 229 million yuan. Its share price has fallen more than 90 percent cumulatively this year.
688496.CG · Regulation · Negative Company received a prior delisting notice from the Shanghai Stock Exchange after its stock closed below 1 yuan for 20 consecutive trading days.
688496.CG · Technology · Negative Core technical staff member Sun Jian resigns, the second core technical departure in three months, weakening the company's technical team.
WTI crude surges $2.45 after China halts fuel exports and U.S. reinforces Middle East presence
West Texas Intermediate crude futures on the New York market closed higher on Thursday, October 1, after reports that China ordered a halt to refined fuel exports, a move that could worsen an already tight global fuel supply picture, and prices also drew support from reports that the United States is sending additional troops and an aircraft carrier to the Middle East. November-delivery WTI crude rose $2.45, or 2.71%, to settle at $92.87 a barrel, while November-delivery Brent crude rose $4.28, or 4.37%, to settle at $102.31 a barrel. Reports said China's government has instructed Chinese refiners to suspend exports of refined fuel products for October in order to preserve domestic stockpiles, after previously announcing in March that it would restrict fuel exports because the war with Iran disrupted crude supplies from the Middle East, before easing those controls in July and managing exports of diesel, gasoline and jet fuel on a monthly basis. On Wednesday, September 30, PetroChina, a major state-controlled Chinese oil company, cancelled a number of planned October shipments of gasoline and jet fuel, while Zhejiang Petrochemical scheduled no fuel product shipments during the holiday week. Prices also rose after The Wall Street Journal reported that the United States is sending a third aircraft carrier and an additional 10,000 troops to the Middle East, as President Donald Trump weighs renewed strikes on Iran after the U.S. midterm elections in November. Trump told reporters at the White House before departing for a campaign event that he is considering various options on Iran, adding that Iran must agree to a fair deal or face collapse. More broadly, although crude supply continues to reach the market, diesel and other refined products remain tight because of damage to refinery infrastructure in the Arabian Gulf region and Russia. Global diesel inventories are tight after Russia, a major exporter, announced it would extend its ban on diesel exports through the end of October, while industry experts expect such supply tightness to persist into next year. President Vladimir Putin said Russia will not export diesel to world markets until sanctions against Russia are lifted.
BRENT · Supply · Positive China's export halt and Middle East tensions tighten supply, lifting Brent $4.28 to $102.31.
WTI · Supply · Positive China's halt of refined fuel exports tightens global fuel supply, pushing WTI crude up $2.45 to $92.87.
HEATOIL · Supply · Positive China's suspension of refined fuel exports and already-tight distillate supplies support heating oil prices.
601857.CG · Regulation · Negative China's government ordered refiners to halt October refined fuel exports, and PetroChina cancelled planned October gasoline and jet fuel shipments.
Chinese State Funds Backed Purchase of Restricted Nvidia AI Chips, Report Says
A Chinese state-backed financing entity funded the purchase of restricted Nvidia processors, according to a Bloomberg News report citing Chinese regulatory filings. The financing, provided by Semi-Tech Leasing Group Co., supported the purchase of more than 700 servers by AI infrastructure developer Glory View Technology Co., and filings with the People's Bank of China cited by Bloomberg show at least one transaction explicitly funded 32 Asustek Computer Inc. servers powered by Nvidia's high-performance B300 Blackwell chips. Nvidia told Bloomberg it is investigating the matter with its equipment manufacturing partners, while Asus reiterated its commitment to international export control regulations. Semi-Tech Leasing, originally established with backing from China's national semiconductor fund and now predominantly controlled by municipal government entities in Shenzhen and Beijing, has deployed more than 11 billion yuan, or $1.6 billion, into compute infrastructure. Under sale-and-leaseback arrangements initiated in mid-2025, Glory View secured over 3 billion yuan, or $450 million, to expand data center capacity, with most of the procured hardware slated for a major China Mobile Ltd. computing hub in Ningxia. After initial scrutiny, Semi-Tech Leasing resubmitted altered filings to Chinese credit registries that removed specific hardware descriptions, supplier details, and server model designations.
Artificial Intelligence › AI Server OEM & System Integration ▼Regulation
Artificial Intelligence › AI Compute Cloud & Neoclouds Regulation
NVDA · Tariff · Negative Report says restricted Nvidia B300 Blackwell chips reached China via state-backed financing, exposing Nvidia to export-control scrutiny it is investigating.
Semi-Tech Leasing Group Co. · Regulation · Negative Semi-Tech Leasing resubmitted altered filings removing hardware and supplier details after scrutiny of its financing of restricted Nvidia chip purchases.
301396.CS · Capital · Neutral Glory View secured over 3 billion yuan in sale-and-leaseback financing to expand data center capacity, but the report frames this around restricted-chip purchases.
2357.TW · Tariff · Negative At least one transaction funded 32 Asustek servers powered by restricted Nvidia B300 chips, and Asus had to reiterate its export-control compliance.
600941.CG · Demand · Neutral Most procured hardware is slated for a China Mobile computing hub in Ningxia, but the article gives no clear positive or negative for China Mobile itself.
Petrobras P-80 Platform Departs Singapore for Buzios Field
Petrobras' P-80 platform, also known as Búzios 9, has left the Tuas Boulevard Yard shipyard in Singapore and is heading toward the Búzios field in Brazil's pre-salt Santos Basin, the first of six giant units being developed by the company and expected to begin production in 2027. The P-80 is designed to produce up to 225,000 barrels of oil and process 12 million cubic meters of natural gas per day, placing it among the largest units of its kind in the global industry. Petrobras' director of engineering, technology and innovation, Renata Baruzzi, said the platform combines high production capacity with advanced technologies and digital solutions intended to enhance operational and energy efficiency. The P-82, next in the series and also scheduled to start production in 2027, is in the final stages of construction, and Petrobras is using a series-based construction approach across the six platforms to reduce costs and improve shipyard productivity. The P-80 process modules were manufactured in Brazil at the Seatrium BrasFELS shipyard in Angra dos Reis, while P-82 modules are being produced at the Seatrium Aracruz shipyard in Espírito Santo, with construction also taking place in China, Singapore and Indonesia. Petrobras operates Búzios in partnership with CNOOC, CNPC and Pré-Sal Petróleo SA (PPSA), and the field set monthly and daily natural gas export records in August, exceeding 10 million cubic meters per day on a monthly basis and reaching 14.1 million cubic meters per day on a daily basis.
Energy Transition & Power Demand › Natural Gas Value Chain ▲Supply
PBR · Supply · Positive Petrobras' P-80 platform departs Singapore for Búzios, adding 225,000 bpd of production capacity as first of six units due in 2027.
Seatrium Limited · Supply · Positive Seatrium built the P-80 at its Tuas Boulevard Yard and is constructing P-82 modules at its BrasFELS and Aracruz shipyards, benefiting from Petrobras' series-based platform construction.
600938.CG · Supply · Positive CNOOC is a partner in the Búzios field, where the P-80 platform is advancing toward first production in 2027, adding future output.
China National Petroleum Corporation · Supply · Positive CNPC is a partner in the Búzios field, which gains future production capacity from the departing P-80 platform.
China Orders Halt to October Oil Exports in Bid to Preserve Domestic Reserves
China has announced a ban on major domestic refineries exporting refined oil products to other regions in October, with the exception of Hong Kong and Macau, amid concerns about domestic oil reserves. Chinese refineries have already suspended exports of refined oil products for October, according to four sources. Earlier, the Chinese government announced restrictions on fuel exports in March as the Iran war disrupted crude oil supplies from the Middle East, but it later eased those controls in July and is now managing exports of diesel, gasoline and jet fuel on a monthly basis. On Wednesday, state-controlled PetroChina cancelled a number of planned shipments of gasoline and jet fuel for October, while Zhejiang Petrochemical scheduled no shipments of oil products during the holiday week. The government has set the condition that exports can proceed only once domestic oil reserves return to pre-Iran war levels. For September, China exported about 1.4 million tons of diesel, 500,000 tons of gasoline and at least 2 million tons of jet fuel, including volumes under the bonded warehouse system for Hong Kong and Macau. Michal Meidan, head of China energy research at the Oxford Institute for Energy Studies, said this reflects that the Chinese government wants to focus on building domestic supply security, while overseas markets are only a secondary matter.
601857.CG · Regulation · Negative PetroChina cancelled planned October gasoline and jet fuel shipments as China's export ban forces refineries to halt refined product exports.
Zhejiang Petrochemical Co., Ltd. · Regulation · Negative Zhejiang Petrochemical scheduled no oil product shipments during the holiday week under China's October export ban.
HEATOIL · Supply · Positive China's halt of refined oil product exports tightens global distillate supply, supporting heating oil prices.
CanadaUnited Arab EmiratesChinaHong Kong SAR China
China
XRG in Talks to Buy Into LNG Canada as PetroChina Holds 15% Stake
Abu Dhabi based XRG P.J.S.C is in talks to buy into the LNG Canada joint venture, where PetroChina currently holds a 15% stake. PetroChina shares trade at HK$9.665, with a 1 month share price return that declined 4.97%, a 90 day share price return of 10.46% and a 1 year total shareholder return of 44.84%. The stock carries a P/E of 8.6x, described as good value versus Hong Kong and Asian oil and gas peer averages of 11.4x and 11.6x and cheap versus an estimated fair P/E of 13.1x. It is also flagged as trading at a 61.4% discount to an internal fair value estimate, with the SWS DCF model putting fair value at HK$25.04 per share. Forecasts point to average annual earnings declines of 1.9% and revenue declines of 1.2% over the next three years, while risks include a slowdown in Mainland China demand or a change in LNG Canada timelines.
Energy Transition & Power Demand › Natural Gas Value Chain Capital
Energy Transition & Power Demand › Firm Power & Transition Fuels Capital
XRG · Capital · Neutral XRG is in talks to buy into the LNG Canada joint venture, but the outcome and terms are unconfirmed.
LNG Canada · Capital · Neutral LNG Canada is the JV asset at the center of the reported stake talks, with timeline risk flagged, but no concrete change to the project is stated.
601857.CG · Capital · Neutral PetroChina's 15% LNG Canada stake is the subject of XRG's reported talks, but no deal terms or confirmed sale are given; article mainly cites valuation metrics and earnings-decline forecasts.
InnovestX Sets 2027 SET Target at 1,715 Points, Says 1,550 Is Starting to Look Attractive
InnovestX Securities has unveiled its investment strategy for the fourth quarter of 2026, saying investors need to exercise greater caution amid rising interest rates and high oil prices, which are pressuring inflation, bond yields, and foreign fund flows. The firm set a target for Thailand's benchmark stock index in 2027 at 1,715 points and said the 1,550 level is starting to look attractive for accumulation. It named five top picks: AMATA, CENTEL, CRC, KTB, and PR9. Suthichai Kumworachai, Head of Investment Strategy & Research, said the prolonged conflict between the United States and Iran creates a chain of risk running from oil prices to inflation, the direction of interest rates, financing costs, and the baht. Dr. Piyasak Manasant, Head of Economic Research, kept his forecast for Thai economic growth in 2026 and 2027 at 2.0% while raising his average oil price assumptions for 2026 and 2027 to 90 and 80 US dollars per barrel, respectively. Sitthichai Duangrattanachaya, Head of Investment Strategy, said earnings per share for the Thai stock market have been continuously revised upward, particularly from the energy sector. For overseas investment, he recommended stocks that benefit from AI, namely Google, Amazon, Nvidia, Tencent, and Alibaba, while in the semiconductor group he highlighted Lumentum, Naura, SMIC, and Biren. He also advised diversifying into defensive and dividend stocks. Joranapong Rattanasopha, Head of Investment Product Specialist, recommended the M-SCHD fund, which invests through the Schwab U.S. Dividend Equity ETF. SCHD currently has less than 10% exposure to technology stocks, compared with nearly 40% for the S&P 500 index, and the correlation between SCHD and the S&P 500 has fallen to about 0.3, the lowest level since the fund was established in 2011.
GNMI Completes Share Transfer for 29.89% Controlling Stake in Zhejiang Jihua
Global New Material International Holdings Limited announced that the registration of the share transfer for its acquisition of approximately 29.89% of the shares of Zhejiang Jihua Group Co., Ltd. was completed with China Securities Depository and Clearing Corporation Limited, Shanghai Branch on 29 September 2026. The transaction, signed on 6 February 2026, took approximately eight months to complete and involved a consideration of RMB1,495 million, with subsequent arrangements including the reorganisation of Zhejiang Jihua's board of directors to proceed in accordance with relevant procedures. Zhejiang Jihua operates the world's third-largest dye production base and reported 1H2026 operating revenue of RMB796 million, up 12.27% year-on-year, and net profit attributable to shareholders of RMB46.16 million, up 1,235.47% year-on-year. GNMI, which acquired CQV in Korea in 2023 and SUSONITY for EUR665 million in July 2025, reported 1H2026 revenue of RMB2,558.3 million, up 180.5% year-on-year, and issued RMB1.3 billion in convertible bonds on 24 September 2026 at an initial conversion price of HK$10.93 per share. Dr SU Ertian has increased his shareholding on multiple consecutive occasions and currently holds 36.4% of the Company's shares.
6616.HK · Capital · Positive GNMI completed the RMB1,495 million share transfer for a 29.89% controlling stake in Zhejiang Jihua, consolidating its acquisition
603980.CG · Capital · Positive GNMI completed its acquisition of a 29.89% controlling stake in Zhejiang Jihua, with board reorganisation to follow
LNG Canada Approves Phase 2 Expansion, Doubling Capacity to 28 Million Tonnes a Year
LNG Canada has approved its Phase 2 export terminal expansion, a decision that will double the project's production capacity compared with its initial build out once completed, bringing capacity to 28 million tonnes a year. PetroChina, the HK$2.3 trillion oil and gas group listed in Hong Kong, is a joint venture partner in LNG Canada and holds a 15% share that now ties into the much larger export platform. LNG Canada also reached an Indigenous ownership agreement with five neighboring First Nations, one of the largest such stakes in Canadian infrastructure, a framework that supports local alignment over the life of the long duration asset. For PetroChina, the Phase 2 greenlight and the Indigenous equity deal reshape what LNG Canada could mean for its long term role in Canada, pointing to more potential offtake and a deeper link into North American gas flows. The key marker investors should watch next is whether talks with Abu Dhabi National Oil Co. unit XRG over a possible stake proceed to a signed transaction or are formally dropped.
Energy Transition & Power Demand › Natural Gas Value Chain ▲Supply
Energy Transition & Power Demand › Firm Power & Transition Fuels Supply
LNG Canada · Supply · Positive LNG Canada approved its Phase 2 expansion, doubling capacity to 28 Mt/y, and reached an Indigenous ownership agreement.
601857.CG · Demand · Positive PetroChina's 15% stake in LNG Canada ties into a doubled 28 Mt/y export platform, pointing to more potential offtake and deeper North American gas flows.
ACM Research Shanghai's Orders in Hand Exceed 17 Billion Yuan, Up Nearly 90% Year on Year
ACM Research Shanghai released a voluntary announcement on the evening of September 30, stating that as of September 29, 2026, the company's total orders in hand amounted to 17.073 billion yuan, an increase of 88.20 percent compared with the orders in hand voluntarily disclosed in the same period last year. The company said that since 2026, the semiconductor equipment manufacturing industry has continued its rapid growth trend, and the company's revenue has maintained sustained growth. The previously released half-year report showed that operating revenue in the first half of the year reached 3.718 billion yuan, up 13.87 percent year on year, while net profit attributable to the parent company was 989 million yuan, up 42.14 percent year on year. The company has already disclosed its full-year 2026 earnings forecast, expecting annual operating revenue to be between 8.2 billion and 8.8 billion yuan.
Semiconductors › Deposition, Etch & Process Tools ▲Demand
688082.CG · Demand · Positive Total orders in hand reached 17.073 billion yuan, up 88.20% year on year, signaling strong customer demand for its semiconductor equipment.
Aoni Electronics announced on the evening of September 30 that its wholly owned subsidiary Aoni Intelligent Technology Zhongshan Company signed a procurement contract with Company C to purchase GPU computing card products, with a total contract value of 1.821 billion yuan including tax. Earlier, on September 24, the company announced at midday that Aoni Intelligent signed a procurement contract with Company B to purchase GPU computing card products, with a total contract value of 232.26 million US dollars, equivalent to approximately 1.556 billion yuan. The company stated that the above contracts are major contracts in the ordinary course of Aoni Intelligent's business, do not require review by the company's board of directors or shareholders' meeting, and do not constitute a related-party transaction or a major asset restructuring. Aoni Electronics said that if the contracts are performed smoothly, they are expected to have a positive impact on the company's operating results for the performance year, with the specific impact amount and reporting period depending on the fulfillment of the orders, while also cautioning that the contracts may not be performed on schedule or in full due to changes in the macroeconomic environment, industry policy adjustments, or force majeure. Financial reports show that in 2025 Aoni Electronics achieved operating revenue of 946 million yuan, with a net loss attributable to shareholders of the listed company of 157 million yuan. In the first half of 2026, operating revenue was 907 million yuan, up 215.44 percent year on year, and net profit attributable to the parent company was 16.8146 million yuan, up 126.22 percent year on year.
China Races to Build Domestic Chipmaking Equipment, Boosting NAURA and AMEC's Market Share
China's chipmaking equipment industry is growing rapidly as wafer fabs across the country turn to buying 100% domestically produced machinery after supply chain restrictions imposed by Western nations. Data from Google Trends for August to September 2026 shows surging keywords including China Semiconductor Tooling Localization and Domestic Wafer Fab Equipment, while retail investors continue searching for ASML China Export Restrictions. One clear beneficiary is NAURA Technology Group, or 002371.SZ, whose product lines cover etching equipment, thin-film deposition, and wafer cleaning tools, placing it close to Applied Materials and allowing Chinese fabs to procure nearly an entire equipment suite in a single package, with its order backlog overflowing under the National Semiconductor Self-Reliance policy. Another is Advanced Micro-Fabrication Equipment, or AMEC, or 688012.SS, a specialist in plasma etching whose CCP and ICP etchers can compete with Lam Research and which has repeatedly won patent cases against major multinational giants, allowing it to rapidly expand its share of the Chinese market from the tens of percent range to a market-leading position.
002371.CS · Demand · Positive NAURA's order backlog is overflowing as Chinese fabs procure its domestic etching, deposition, and cleaning equipment.
688012.CG · Demand · Positive AMEC is winning Chinese fab orders and expanding its share to a market-leading position as fabs buy domestic tools.
AMAT · Competition · Negative NAURA's near-complete equipment suite lets Chinese fabs buy domestically instead of from Applied Materials, threatening its China share.
LRCX · Competition · Negative AMEC's CCP/ICP etchers compete with Lam Research and are rapidly gaining Chinese market share.
Novo Licenses Hengrui's Oral GLP-1 Candidate HRS-1596 in Deal Worth Up to $2.6 Billion
Novo Nordisk has signed a licensing agreement with Hengrui Pharma for HRS-1596, a phase I-ready GLP-1/GIP dual receptor agonist with potential for once-weekly oral dosing. Under the deal, Novo gains exclusive rights to develop, manufacture and commercialize the candidate globally outside mainland China, Hong Kong, Macao and Taiwan, with a total potential value of up to $2.6 billion including a $300 million upfront payment plus potential sales royalties; Hengrui has received approval in China to begin phase I studies of HRS-1596 for weight management and type II diabetes, and the transaction is expected to close in the fourth quarter subject to regulatory and customary conditions. The agreement builds on Novo's February partnership with Vivtex, under which Vivtex licensed selected oral drug-delivery technologies to Novo and is eligible for up to $2.1 billion in upfront consideration, research funding and milestone payments plus royalties, and on last year's exclusive global collaboration with Septerna, which received a $195 million upfront payment under an agreement providing for approximately $2.2 billion across upfront, research, development and commercial milestone payments plus tiered royalties. Novo is pursuing this external innovation strategy because semaglutide-based products, comprising Ozempic and Rybelsus for T2D and Wegovy for obesity, generated roughly 75.5% of its adjusted first-half 2026 sales, leaving it heavily exposed to competition and exclusivity shifts. Rival Eli Lilly's tirzepatide-based Mounjaro generated $18.6 billion in first-half 2026 sales, up 106%, while Zepbound sales rose 60% to $9.1 billion, and Lilly's oral obesity treatment Foundayo launched in the United States in April and is under regulatory review in more than 40 additional countries. Novo's first-half Ozempic sales declined 2% at constant exchange rates while Wegovy product sales increased 7%, and its latest outlook calls for both adjusted sales and adjusted operating profit to decline 0% to 6% at constant exchange rates in 2026.
Biotech & Genomic Medicine › Metabolic, Diabetes & Obesity Competition
600276.CG · Capital · Positive Hengrui licenses HRS-1596 to Novo for up to $2.6B including a $300M upfront payment plus royalties.
NVO · Capital · Positive Novo gains global rights to Hengrui's oral GLP-1/GIP candidate HRS-1596 for up to $2.6B, expanding its pipeline beyond semaglutide.
LLY · Competition · Negative Novo's licensing of an oral GLP-1/GIP candidate strengthens a rival in the obesity/diabetes market where Lilly's tirzepatide and oral Foundayo compete.
Memory stocks face pricing test ahead of Micron earnings
Memory stocks are facing a fresh test as pricing momentum cools ahead of Micron Technology's earnings on Wednesday. Sara Awad of Tech Contrarians said the performance of memory players without significant high-bandwidth memory exposure could offer a better read on non-AI memory demand and pricing, which will be critical to Micron's gross-margin outlook. Among the names Awad highlighted, WT Micro reported August sales growth of only 8%, while Nanya Technology posted record August sales of NT$44.7B but monthly growth slowed to 2% from 49% in July, and Macronix International recorded a roughly 5% monthly increase in August, a slowdown from July. Awad noted that DRAM average selling prices could rise only 13%-18% in Q3, according to TrendForce, compared with roughly 50%-60% growth in Q2, while additional Chinese supply is coming online, with CXMT expected to reach roughly 20,000 wafer starts per month by year-end. Micron guided for an 86% gross margin last quarter after reporting 84.6%, and Awad said the market could react negatively if the company fails to guide for another increase.
MU · Pricing · Negative DRAM ASP growth cooling to 13-18% in Q3 from 50-60% in Q2 and rising CXMT supply threaten Micron's gross-margin outlook ahead of earnings.
2337.TW · Demand · Negative Macronix's August sales growth slowed to ~5% monthly from July, signaling weakening non-AI memory demand.
2408.TW · Demand · Negative Nanya posted record August sales but monthly growth decelerated sharply to 2% from 49% in July, indicating cooling memory demand.
688825.CG · Supply · Negative CXMT's additional Chinese DRAM supply, expected to reach ~20,000 wafer starts per month by year-end, adds capacity pressure on memory pricing.
Ford, GM and Stellantis invest under $400 per vehicle in EVs as Chinese rivals spend up to $2,750, analyst warns
Ford, GM and Stellantis each invest less than $400 toward EV research, development and production for every passenger vehicle they sell, while Chinese automakers including BYD, SAIC and Geely invest between $1,700 and $2,750 per vehicle, according to Dale Hall of the International Council on Clean Transportation. Writing in Automotive News, Hall said the Detroit 3 ranked among the world's five least capital-invested automakers in EVs on a sales-adjusted basis as of last year, and warned that no amount of American ingenuity and innovation can close the gap with China's lead. He pointed to the federal government's phase-out of tax credits for new and used electric vehicles and charging infrastructure and its freeze and termination of grants for EV and battery manufacturing, after U.S. makers invested billions in EV projects backed by Inflation Reduction Act assurances. Ford took a $19.5-billion hit tied to scaling back its electric program amid lower-than-expected demand, high costs and regulatory changes. Hall noted China supplies an estimated 70% of the world's car batteries and 80% of car battery cells and has more than 24 times more publicly-accessible EV chargers than the U.S., while BYD overtook Tesla as the world EV leader in 2025.
Electrification & Mobility › China NEV Leaders ▲Competition
F · Capital · Negative Ford invests under $400 per vehicle in EVs versus up to $2,750 by Chinese rivals, and took a $19.5-billion hit from scaling back its electric program.
GM · Capital · Negative GM is among the Detroit 3 investing under $400 per vehicle in EVs, far behind Chinese automakers' $1,700-$2,750.
STLA · Capital · Negative Stellantis is among the Detroit 3 investing under $400 per vehicle in EVs, far behind Chinese automakers' $1,700-$2,750.
002594.CS · Competition · Positive Article highlights BYD's far higher EV investment per vehicle and its overtaking of Tesla as world EV leader, underscoring its competitive lead over the Detroit 3.
0175.HK · Capital · Positive Geely invests between $1,700 and $2,750 per vehicle in EVs, giving it a capital-investment lead over the Detroit 3.
600104.CG · Capital · Positive SAIC invests between $1,700 and $2,750 per vehicle in EVs, giving it a capital-investment lead over the Detroit 3.
Chinese Companies Delay Hong Kong IPOs in Succession as Overheated Market Normalizes
A wave of postponed Hong Kong initial public offerings by Chinese companies is signaling that an overheated market is beginning to normalize. In Hong Kong trading on the afternoon of the 30th, Citi raised its target price for Guangzhou Automobile Group while maintaining a neutral rating, and JPMorgan initiated coverage of Chery Automobile with an overweight rating. Nomura pointed to accelerating licensing of Chinese new drugs by U.S. companies as a reason for its bullish view on drug discovery-related shares, while Citi issued a buy rating on Xiaomi, expecting a recovery in smartphone margins and an expansion of its EV business through new model launches. Share buybacks in the Hong Kong market totaled 28.6 billion yen across 97 stocks, and Shenzhen Hichain Technology closed at 215.2 Hong Kong dollars on its debut, up 265.7 percent from its offer price. In China, Standard Chartered flagged the possibility of additional monetary easing including cuts to the reserve requirement ratio, and DeepSeek released foundational software for Huawei's Ascend chips, taking a step toward reducing reliance on Nvidia.
China Telecom's TeleOCR Tops Global Document Parsing Benchmarks
China Telecom Artificial Intelligence Technology Co., Ltd. announced that TeleOCR, its self-developed document parsing model, has set a new state-of-the-art result on OmniDocBench v1.6 with an overall score of 96.87 out of 100. The model, open-sourced by China Telecom's Xingchen AGI Lab with roughly 1.2 billion parameters, also ranked first on two other benchmarks and took first place in the ICDAR 2026 Sci-ImageMiner Challenge for scientific figure understanding. On Wild-OmniDocBench v1.5 it scored 88.53 on camera-captured documents, about one point ahead of the runner-up, while on PureDocBench it averaged 78.41 across three tracks, including a four-point lead on the most challenging real degradation track. TeleOCR outperformed larger specialized models including MinerU 2.5-Pro and PaddleOCR-VL-1.6 as well as general-purpose models such as Gemini 3 Pro and GPT-5.2, with its code and weights open-sourced on GitHub and Hugging Face and a production-ready API available on China Telecom's Tianyi AI Open Platform. The research team said the next phase will focus on integration into enterprise scenarios including financial document processing, medical record digitization, academic research workflows and government archives.
601728.CG · Technology · Positive China Telecom's TeleOCR document parsing model sets state-of-the-art benchmark results and is open-sourced with a production API
中国电信人工智能科技有限公司 · Technology · Positive China Telecom AI subsidiary's TeleOCR tops global document parsing benchmarks and plans enterprise integration
Gotion Begins Delivery of Africa's Largest AC-Coupled Storage Project in Egypt
Gotion has launched global delivery for what will be Africa's largest AC-coupled energy storage project, with the first 50 heavy-duty trucks carrying its self-developed Gotion Grid 5MWh storage systems departing simultaneously from its Jinzhai and Nantong facilities on Sept. 28. The shipment came within three months of signing, a pace Gotion attributes to its vertically integrated supply chain and upstream-downstream coordination. The Gotion Grid systems will serve Egypt's Nefertiti and Horus projects, the country's first large-scale standalone storage projects and, once completed, Africa's largest standalone storage facilities. Developed by AMEA Power and built by China Energy Engineering Group, the projects are designed to strengthen grid stability, support solar and wind integration, and advance Egypt's 2030 clean energy goals, with systems upgraded for extreme heat, sandstorms and salt fog and offering high-voltage stability, high safety and millisecond-level response. Hussain Al Nowais, Chairman of AMEA Power, said the shipment opens a new stage of broader cooperation, while Li Chen, Senior Vice President of Gotion and President of Gotion Americas, called Egypt Gotion's key step into the Middle East and North Africa.
002074.CS · Demand · Positive Gotion began delivering its self-developed Gotion Grid 5MWh storage systems for Africa's largest AC-coupled storage project in Egypt.
601868.CG · Demand · Positive China Energy Engineering Group is the builder of Egypt's Nefertiti and Horus storage projects, which are now receiving Gotion's systems for construction.
AMEA Power · Demand · Positive AMEA Power is the developer of the Nefertiti and Horus storage projects, whose first shipment of Gotion systems has departed.
Niutech Completes Group Restructuring, Launches Large Pyrolysis Line
Niutech Technology Group Co., Ltd. completed its group restructuring on August 26, 2026, building on nearly 40 years of work in industrial continuous pyrolysis. The company's new-generation large industrial continuous intelligent pyrolysis line handles over 100 tonnes per day per unit for both waste tires and waste plastics, with recovered carbon black toluene transmittance raised above 80%. In China, Niutech's majority-owned subsidiary Hesheng Environmental Protection, the first continuous tire recycling project in China and the first in the sector to obtain ISCC certification, launched a 100,000-tonne Phase II project in 2026 that lifts capacity to 160,000 tonnes per year. A UK customer signed an order worth RMB 198 million after assessing Niutech's European and Chinese projects and comparing the company against peers worldwide. Niutech is now accelerating research on extending the clean tire pyrolysis oil chain and new blending pathways toward SAF and other clean alternative energy with overseas energy majors and in-house R&D.
688309.CG · Demand · Positive UK customer signed a RMB 198 million order after comparing Niutech against global peers, and its Hesheng subsidiary launched a 100,000-tonne Phase II tire recycling project.
688309.CG · Technology · Positive New-generation large continuous pyrolysis line handles over 100 tonnes/day per unit with recovered carbon black toluene transmittance above 80%, plus R&D toward SAF blending pathways.
AstraZeneca to Invest $2 Billion in Summit; CanSino Biologics Hits 20-Cent Daily Limit Up
On September 29, Summit announced that AstraZeneca will make a strategic equity investment of $2 billion in the company and will take the lead in advancing clinical research on ivonescimab combined with AstraZeneca's Sonesitatug Vedotin for the treatment of multiple gastrointestinal tumors. The two parties also plan to further promote clinical exploration of combination therapies involving ivonescimab and a range of AstraZeneca antibody-drug conjugates and other anti-tumor drugs. Boosted by this news, innovative drug concept stocks were repeatedly active in early trading on September 30. CanSino Biologics hit the 20-cent daily limit up, Berry Genomics hit the daily limit up, and Sino Biological, Tri-Prime Gene, and Walvax Biotechnology quickly followed with gains. On the same day, China's three major A-share indices opened collectively higher. As of press time, the Shanghai Composite Index rose 0.35 percent, the Shenzhen Component Index rose 0.48 percent, the ChiNext Index rose 0.92 percent, and the SSE STAR 50 Composite Index rose 0.31 percent. By sector, biotechnology, power generation equipment, and gas were relatively active, while the real estate sector led declines, and internet, semiconductor, and software sectors fluctuated in adjustment.
Biotech & Genomic Medicine › Oncology Therapeutics ▲Capital
Biotech & Genomic Medicine › Immuno-Oncology / Checkpoint ▲Capital
Biotech & Genomic Medicine › Antibody-Drug Conjugates (ADC) ▲Capital
AZN.LSE · Capital · Positive AstraZeneca will make a $2 billion strategic equity investment in Summit and lead clinical research on ivonescimab combinations.
Summit Hosting LLC · Capital · Positive Summit announced AstraZeneca's $2 billion strategic equity investment and a lead role in advancing ivonescimab combination clinical research.
688185.CG · Demand · Positive CanSino Biologics hit the 20-cent daily limit up as part of the innovative drug concept rally sparked by AstraZeneca's Summit investment, but no company-specific development is cited.
National Day holiday airfares rise 11.2% year on year; China Eastern, China Southern and Hainan Airlines add capacity
After lower prices during the summer travel season, the civil aviation market saw a round of price recovery over the National Day holiday. Data from Flight Master shows that as of 29 September, the weighted average tax-inclusive price for domestic economy class during the 2026 National Day holiday was 929.7 yuan, up 11.2% from 836 yuan in the same period of 2025; the average base fare was 820.2 yuan, up 6% year on year. Data from Umetrip shows that domestic flight bookings for the National Day holiday have exceeded 9.86 million tickets, while inbound and outbound flight bookings reached about 1.59 million tickets, up about 2% year on year. To cope with the peak passenger flow, airlines continued to add holiday capacity: China Eastern Airlines, together with its subsidiaries Shanghai Airlines and China United Airlines, plans to operate more than 39,000 flights between 25 September and 7 October, carrying more than 5.8 million passengers, and plans to add more than 800 extra flights and upgrade more than 270 flights to wide-body aircraft. China Southern Air Holding plans to operate more than 27,000 flights between 30 September and 8 October, including more than 23,000 domestic flights and about 4,000 international and regional flights, and plans to use the C919 on more than 400 domestic flights. Hainan Airlines plans to operate nearly 6,500 domestic and international flights during the National Day holiday, carrying an estimated 1.1 million passengers, including 582 international and regional flights, up 2.4% year on year.
Nexchip Semiconductor to Boost Stake in Anhui Jingmei to 32.1599% in 908 Million Yuan Capital Increase
Nexchip Semiconductor announced after market close on September 30 that it plans to use its 100% equity stake in wholly owned subsidiary Hefei Jingwei Technology Co., Ltd., valued at 908.2533 million yuan, to increase capital in Anhui Jingmei Photomask Co., Ltd. Upon completion, Nexchip Semiconductor's direct shareholding in Anhui Jingmei will rise from 16.6667% to 32.1599%, and Anhui Jingmei's registered capital will increase from 1.2 billion yuan to approximately 3.247 billion yuan. The pricing of this capital increase is based on an appraisal, with Anhui Jingmei's pre-investment valuation at 1.291 billion yuan. Each investor will subscribe at a price of 1.0758 yuan per unit of registered capital, of which 844.2585 million yuan will be credited to registered capital and 63.9948 million yuan to capital reserve. This transaction constitutes a related-party transaction, as Anhui Jingmei is a 30%-controlled company of the company's controlling shareholder, Hefei Construction Investment Holding Group Co., Ltd., and the company's current chairman, Cai Guozhi, serves as Anhui Jingmei's legal representative and chairman. Related directors recused themselves from voting during board deliberations, and the matter still requires approval by the company's shareholders' meeting. Nexchip Semiconductor stated that this transaction will help revitalize existing assets, achieve centralized allocation and efficient use of photomask production resources, and enhance supply chain stability and self-reliance.
688249.CG · Capital · Positive Nexchip is increasing its stake in Anhui Jingmei via a 908 million yuan capital injection, consolidating photomask assets and supply chain.
安徽晶镁光罩有限公司 · Capital · Positive Anhui Jingmei receives a 908 million yuan capital increase, raising registered capital to ~3.247 billion yuan.
合肥晶为科技有限公司 · Capital · Neutral Hefei Jingwei's 100% equity is being contributed by Nexchip into Anhui Jingmei, transferring ownership of the subsidiary.
Lakala Plans Share Issuance and Cash Payment to Acquire Controlling Stake in Guangzhou Gaofu Information Technology; Trading Suspended from October 8
Lakala announced that the company is planning to acquire a controlling stake in Guangzhou Gaofu Information Technology Co., Ltd. through the issuance of shares and cash payment. As there is still uncertainty regarding related matters, trading in the company's securities will be suspended from market open on October 8, 2026, and the transaction plan is expected to be disclosed within no more than 10 trading days.
Digital Finance & Tokenization › Payments Modernization & Rails Capital
300773.CS · Capital · Neutral Lakala plans to acquire a controlling stake in Guangzhou Gaofu via share issuance and cash, with trading suspended pending disclosure.
Xinhua Media hits 7th consecutive daily limit up, plans to acquire 100% of Shanghai Interface Cailianshe Technology
Xinhua Media hit the daily limit up again on September 30, recording its seventh consecutive limit-up. On the evening of September 29, Xinhua Media issued an announcement on abnormal stock trading fluctuations and a risk warning, stating that since resuming trading, its cumulative gain had reached 77.21%, with relatively large short-term volatility. As of September 28, the latest rolling price-to-earnings ratio for the company's industry, news and publishing, was only 17.47, while the company's latest rolling price-to-earnings ratio was 209.34, significantly higher than the industry average, and there may be irrational speculation. Previously, on September 19, Xinhua Media issued a preliminary plan announcement for a share issuance to purchase assets and a related-party transaction, proposing to buy 100% equity in Shanghai Interface Cailianshe Technology from 13 counterparties including Shanghai United Media Group Culture New Media Investment Management. The transaction is expected to constitute a major asset restructuring. According to the announcement on the evening of September 29, as of September 29, the audit and evaluation work involved in this major asset restructuring had not yet been completed, and the necessary internal decision-making procedures still needed to be fulfilled. It can only be formally implemented after approval by the competent regulatory authorities, and there is uncertainty as to whether the transaction can obtain approval from the relevant authorities and the timing of final approval.
600825.CG · Capital · Neutral Xinhua Media plans a major asset restructuring to acquire 100% of Shanghai Interface Cailianshe Technology, but audit/valuation is incomplete and regulatory approval is uncertain.
Naruida Radar Plans to Acquire 51% Stake in Xintai Communications for 162 Million Yuan
Naruida Radar announced that the company intends to use its own funds of 162 million yuan to acquire a 51% stake in Guangzhou Xintai Communication Technology Co., Ltd. After the transaction is completed, Xintai Communications will become a controlling subsidiary of the company. The target company was established in 2013 and is committed to providing integrated optical transmission systems and optical transmission optimization solutions. It is a domestic optical communication product manufacturer and optical transmission solution provider. Its products include wavelength division optical transmission systems, DCI metropolitan wavelength division systems, OTN intelligent optical network systems, optical amplification systems, optical protection systems, and optical device product series, mainly applied in industries such as telecom operators, ISPs, IDCs, electric power, electronics, information communications, network security, and cloud computing. The counterparty has committed that the target company's non-GAAP net profit from 2026 to 2028 will be no less than 25 million yuan, 29 million yuan, and 38 million yuan, respectively.
Artificial Intelligence › Optical Interconnect & DCI Capital
688522.CG · Capital · Positive Naruida Radar is acquiring a 51% controlling stake in Xintai Communications for 162 million yuan, an M&A transaction that adds a profitable subsidiary with committed net profit guarantees.
广州芯泰通信技术有限公司 · Capital · Positive Xintai Communications is being acquired at a 51% controlling stake for 162 million yuan, with profit commitments of 25/29/38 million yuan for 2026-2028.
